http://www.OncoLyticVirus.org
Table I – OVs targeting oncogenic ras or defective IFN pathways.

Virus (Company, if known)

Viral gene defect

Cellular Target

Tumor models

References

Influenza A

NS1

PKR

Melanoma

(1)

HSV1mutants: R3616, 1716, G207 (Medigene, Inc.), MGH1

ICP34.5

Protein phosphatase 1a, Defective interferon signaling.

Brain, Colorectal, ovarian, lung, prostate, breast

(2, 3)

Reovirus (Oncolytics Biotech., Inc.)

None

Overactive Ras pathway

Brain, ovarian, breast, colorectal

(4-7) .

VSV

None

Defective Interferon signaling

Melanoma

(8)

Newcastle disease virus (Provirus)

None

Overactive Ras pathway

Fibrosarcoma, Neuroblastoma

(9)


Disclaimer About Medical Information: The information and reference materials contained herein is intended solely for the information of the reader. It should not be used for treatment purposes, but rather for discussion with the patient's own physician.
[Divider]
electronswebs
All Rights Reserved. Copyright © 2004 E.A. Chiooca, MD
Last modified: Thursday, April 20, 2006 5:04 PM .
Site Issues Contact: Webmaster Email